Q: Recently your team viewed MDLZ as expensive. I'm assuming that this is mainly based on squeezed margins and lower earnings (?), because I see P/S and P/CF as reasonable.
I know GIS likely shares similar issues. Technically, if GIS got to the $32 level, it would seem like an extremely good buy if it could ever get the margins under control.
Do you see either as a better buy than the other? I would assume that there would be no concern on either company's debt or dividend ?
I know GIS likely shares similar issues. Technically, if GIS got to the $32 level, it would seem like an extremely good buy if it could ever get the margins under control.
Do you see either as a better buy than the other? I would assume that there would be no concern on either company's debt or dividend ?